Who is sponsoring NCT06232525?

NCT06232525 is sponsored by Alev Esercan.

What drugs are being tested in NCT06232525?

Interventions in NCT06232525: transobturator tape operation (TOT), urethral ligament plication.

What condition does NCT06232525 study?

NCT06232525 studies Stress Incontinence, Female.

Is NCT06232525 still recruiting?

NCT06232525 is currently completed. Last updated 3 April 2025.

Last reviewed 2025-04-03 · How we verify

NCT06232525: added

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized Comparison of Transobturator Tape With the Plication of Urethral Ligaments in the Treatment of Stress Urinary Incontinence

Completed NA Last updated 3 April 2025

What this trial tests

NA trial testing transobturator tape operation (TOT) in Stress Incontinence, Female in 108 participants. Completed in 1 March 2025.

Timeline

2 January 2024

Primary endpoint
1 February 2025

1 March 2025

Quick facts

Lead sponsor	Alev Esercan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	108
Start date	2 January 2024
Primary completion	1 February 2025
Estimated completion	1 March 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

transobturator tape operation (TOT)
urethral ligament plication

Conditions studied

Stress Incontinence, Female — all drugs for Stress Incontinence, Female →

Sponsor

Alev Esercan

Who can join

18 and older, female only, with Stress Incontinence, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare the efficacy of transobturator tape (TOT) operation and urethral ligament plication operation in stress incontinence patients. The main question: * Which operation is more effective in treatment of stress incontinence? * Which operation has less complication and risks? Participants will be followed about 5 days, 2.5 months, 6 months and 1 year after the operation and asked about the continence status and complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stress Incontinence, Female

Currently open trials in the same condition.

NCT06885463 — PRP & PDO Threads in Treatment of Stress Incontinence · NA · recruiting

Other Alev Esercan trials

Trials by the same sponsor.

NCT07384117 — Long-term Outcomes of Urethral and Uterosacral Ligament Plication · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06232525 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alev Esercan
Last refreshed: 3 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06232525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing